Varicella-zoster immune globulin
Highest phase reached
Phase 1
Drug type
Unknown
- Listing at source
- Listed
- Highest phase reached
- Phase 1
- Drug type
- Unknown
- Drug name
- Varicella-zoster immune globulin
- varicella
- Varicella
- Varicella (Varilrix®)
- varicella zoster immune globulin
- Varicella zoster immune globulin
- varicella zoster immunoglobulin
- Varicella-zoster immune globulin
- Varicella/zoster immunoglobulin
- varizig
- Varizig
- VariZIG
- VariZIG™
- ATC classification codes
- J06BB03
Sources for recorded values
- ChEMBL ID
- CHEMBL2108828
- RxNorm IDs (RxCUI)
- 39385
- Patents
- 0
- Designations
- 1
- Earliest recorded loss of exclusivity
- 20 Dec 2019
- First in class
- No
- Fast track
- No
- Breakthrough designation
- No
- Orphan designation
- No
- Priority review
- No
- Orphan exclusivity
- No
- Accelerated approval
- No
- Drug name stem
- -bulin
Investigated indications
- Condition
- Chickenpox
- Highest recorded phase
- 1
- Condition identifier
- EFO:0007204
- Subject identifier
- D002644
- Condition identifier
- EFO_0006509
- Condition identifier
- EFO_0007204
- Condition identifier
- MONDO_0005608
- Highest recorded phase
- 4
- Condition identifier
- MONDO_0041052
- Condition identifier
- MONDO_0041052
- Highest recorded phase
- 4
- Event
- hepatic cyst
- Reports
- 2
- Reporting signal score
- 10.7925
- Event
- hepatic haematoma
- Reports
- 2
- Reporting signal score
- 14.0129
- Event
- hepatitis b core antibody positive
- Reports
- 2
- Reporting signal score
- 14.6736
- Event
- laryngeal disorder
- Reports
- 2
- Reporting signal score
- 13.5567
- Event
- microcytic anaemia
- Reports
- 2
- Reporting signal score
- 10.7925
- Event
- varicella
- Reports
- 6
- Reporting signal score
- 40.278
Trial references
- NCT06068608
- Prodrug
- No
- Chirality
- Single enantiomer
- Inorganic
- No
- Natural product
- No
Related records
Trials (89)
- A Clinical Study of a Zoster Vaccine in Healthy Adults >= 40 Years
- A Phase I/II Trial of Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naive Infants
- A Safety and Immune Study of 2 Types of GlaxoSmithKline's Varicella Vaccines Given as a 2-doses Course to Healthy Children 12-23 Months of Age.
- A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Infants and Toddlers
- A Study of Dengue Vaccine in Healthy Toddlers Aged 12 to 15 Months in the Philippines
- A Study of MG1111 in Healthy Children
- A Study of ProQuad in Healthy 4 to 6 Year Old Children (V221-014)
- A Study of ProQuad™ in Healthy Children in Korea (V221-023)
- A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age
- A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age
- A Study on the Immune Response and Safety of the Second Dose of an Investigational Chickenpox Vaccine When Given to Healthy Children 3 Months After a First Dose at 12 to 15 Months of Age
- A Study on the Immune Response and Safety of Various Potencies of an Investigational Chickenpox Vaccine Compared With a Marketed Chickenpox Vaccine, Given to Healthy Children 12 to 15 Months of Age
- A Study on the Safety of an Investigational Chickenpox Vaccine, When Given to Healthy Children, 12 to 15 Months of Age
- A Study to Evaluate the Safety and Immunogenicity of ChAdOx1-VZV in Healthy Adults Aged 50-65 Years
- A Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamic Profile of TNM005 in Healthy Adult Subjectsy
- An Efficacy Study of GlaxoSmithKline (GSK) Biologicals' Candidate Influenza Vaccine GSK2321138A in Children
- Assessment of Antibody Persistence in Children Previously Vaccinated With Pneumococcal Conjugate Vaccine
- Clinical Trial of Recombinant Herpes Zoster Vaccine (CHO Cell) in Healthy Chinese Population Aged 40 Years and Older
- Co-administration Study of an Investigational Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers
- Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTM
In development for (1)
- Chickenpox Phase 1
Other linked conditions (2)
- Postherpetic neuralgia
- Varicella zoster infection